BN changes
Pick any two versions below to diff them.
- Price
- $36.49 → $36.46(−0.1%)
- Thesis
- The market prices Brookfield Corporation below management's own estimate of its worth, called "plan value," for three reasons. First, the structure is hard to value from the outside. A parent company owns most of a public asset manager, an insurance arm, and a group of operating businesses, and money moves between them. In Q2 2026, $45 billion of BAM's $77 billion of new capital came from Brookfield's own insurer. Second, official IFRS profit is much lower and choppier than the distributable earnings figure that management uses. Third, interest rates went up. The Fed raised rates in September 2026, and the 10-year Treasury yield went above 5%. About 45% of plan value is listed holdings at market prices, and these prices fall when long rates rise. Higher rates also slow the asset sales that pay carried interest, and they lower real estate values. Plan value has also come in below the path of the year before for three years in a row, and the target date moved from 2030 to 2031. For the gap to close, the merger with Brookfield Wealth Solutions must close by the end of 2026. Distributable earnings per share must keep growing near 12% a year or more. Realized carried interest must grow from about $0.5 billion a year toward about $1 billion a year by 2027 or 2028. Plan value must grow each year without another move of the target date, and long rates must stop rising. The evidence comes at BAM's Q3 report onin early November 6, 2026, Brookfield's Q3 report in mid-November 2026, the merger close, the change to US accounting rules on January 1, 2027, and the next Investor Day, around September 2027, which shows plan value at June 30, 2027. The gap can close partly over the next four to six quarters if rates stop rising. But the multi-layer structure stays after the merger, so part of the discount may never close.